pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Preclinical
    BEAM-304
    Phenylketonuria (PKU)$BEAM Beam Therapeutics Inc.
  • BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
    BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
    no indication ANI PHARMS
  • BENZAMYCIN
    BENZAMYCIN (ERYTHROMYCIN AND BENZOYL PEROXIDE)
    no indication VALEANT INTL
  • BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5%
    BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5%
← prev
page 62 of 231
next →
131
Pain89
Neurology1
no indication
ALEMBIC
  • BETADINE
    BETADINE (POVIDONE-IODINE)
    no indication ALCON PHARMS LTD
  • BETAINE ANHYDROUS
    BETAINE ANHYDROUS
    no indication$ETON Eton Pharmaceuticals, Inc.
  • Phase 1
    BETR-001
    Major Depressive Disorder Better Life Pharmaceuticals Inc
  • Preclinical
    BF-844
    Usher Syndrome Case Western Reserve University
  • Preclinical
    BG-22
    Solid Tumor BioStar Pharmaceuticals Inc
  • Preclinical
    BG-319
    Type 1 Diabetes (Juvenile Diabetes) Bioorg3.14 LLC
  • Preclinical
    BGA-002
    Small-Cell Lung Cancer Biogenera SpA
  • Phase 2
    BGB-16673
    Refractory Chronic Lymphocytic Leukemia (CLL)$ONC BeOne Medicines Ltd.
  • Phase 1
    BGBB-2033
    Metastatic Hepatocellular Carcinoma (HCC)$ONC BeOne Medicines Ltd.
  • Phase 2
    BGC-101
    Peripheral Arterial Disease (PAD)/ Peripheral Vascular Di… BiogenCell Ltd
  • Phase 1
    BGC-515
    Malignant Mesothelioma BridGene Biosciences Inc
  • Preclinical
    BGI-9004
    Malignant Mesothelioma BridGene Biosciences Inc
  • Phase 1
    BGM-1812
    Obesity BrightGene Bio-Medical Technology Co Ltd
  • Preclinical
    BGT-DTDS
    Neurology Bloomsbury Genetic Therapies Ltd
  • Preclinical
    BGT-INAD
    Neurodegenerative Diseases Bloomsbury Genetic Therapies Ltd
  • Preclinical
    BGT-NPC
    Niemann-Pick Disease Type C Bloomsbury Genetic Therapies Ltd
  • Preclinical
    BGTF-027
    Achromatopsia Blue Gen Therapeutics Foundation
  • Phase 1
    BH-30236
    Refractory Acute Myeloid Leukemia BlossomHill Therapeutics Inc
  • Phase 1
    BH-3120
    Solid Tumor Hanmi Pharmaceuticals Co Ltd
  • Phase 2
    BHV-1510
    Solid Tumor$BHVN Biohaven Ltd.
  • Phase 1
    BHV-1530
    Glioblastoma Multiforme (GBM)$BHVN Biohaven Ltd.
  • Phase 2
    BI-1206
    B-Cell Non-Hodgkin Lymphoma BioInvent International AB
  • Phase 2
    BI-1808
    Mycosis Fungoides BioInvent International AB
  • Phase 2
    BI-1819479
    Idiopathic Pulmonary Fibrosis Boehringer Ingelheim International GmbH
  • Phase 2
    BI-836858
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Boehringer Ingelheim International GmbH
  • BIDIL
    BIDIL (HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE)
    no indication AZURITY